Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/06/24 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
4 | |
| 05/06/24 | 8-K | Current report filing |
|
   |
3 |
| 04/16/24 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
39 | |
| 04/16/24 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
39 | |
| 04/15/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
47 |
| 04/08/24 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
4 | |
| 04/08/24 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
4 | |
| 04/08/24 | 8-K | Current report filing |
|
|
3 |
| 03/28/24 | 8-K | Current report filing |
|
|
3 |
| 03/08/24 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
